153 related articles for article (PubMed ID: 7623442)
21. Thioredoxin and glutathione in cultured fibroblasts from human cases with 5-oxoprolinuria and cystinosis.
Larsson A; Holmgren A; Bratt I
FEBS Lett; 1978 Mar; 87(1):61-4. PubMed ID: 631333
[No Abstract] [Full Text] [Related]
22. Progressive retinal dystrophy in two sisters with glutathione synthetase (GS) deficiency.
Ristoff E; Burstedt M; Larsson A; Wachtmeister L
J Inherit Metab Dis; 2007 Feb; 30(1):102. PubMed ID: 17206463
[TBL] [Abstract][Full Text] [Related]
23. Correction of fumarylacetoacetate hydrolase deficiency (type I tyrosinemia) in cultured human fibroblasts by retroviral-mediated gene transfer.
Phaneuf D; Hadchouel M; Tanguay RM; Bréchot C; Ferry N
Biochem Biophys Res Commun; 1995 Mar; 208(3):957-63. PubMed ID: 7702626
[TBL] [Abstract][Full Text] [Related]
24. Effect of decreased glutathione levels in hereditary glutathione synthetase deficiency on dibromoethane-induced genotoxicity in human fibroblasts.
DeLeve LD
Mutat Res; 1997 Mar; 389(2-3):291-7. PubMed ID: 9093395
[TBL] [Abstract][Full Text] [Related]
25. Five Chinese patients with 5-oxoprolinuria due to glutathione synthetase and 5-oxoprolinase deficiencies.
Li X; Ding Y; Liu Y; Ma Y; Song J; Wang Q; Yang Y
Brain Dev; 2015 Nov; 37(10):952-9. PubMed ID: 25851806
[TBL] [Abstract][Full Text] [Related]
26. Tyrosinaemia type I--an update.
Kvittingen EA
J Inherit Metab Dis; 1991; 14(4):554-62. PubMed ID: 1749221
[TBL] [Abstract][Full Text] [Related]
27. A case of severe glutathione synthetase deficiency with novel GSS mutations.
Xia H; Ye J; Wang L; Zhu J; He Z
Braz J Med Biol Res; 2018 Jan; 51(3):e6853. PubMed ID: 29340523
[TBL] [Abstract][Full Text] [Related]
28. 5-Oxoprolinuria in patients with and without defects in the gamma-glutamyl cycle.
Mayatepek E
Eur J Pediatr; 1999 Mar; 158(3):221-5. PubMed ID: 10094443
[TBL] [Abstract][Full Text] [Related]
29. Gas Chromatography Mass Spectrometry Aided Diagnosis of Glutathione Synthetase Deficiency.
Kaur P; Chaudhry C; Panigrahi I; Srivastava P; Kaur A
Lab Med; 2022 May; 53(3):e59-e61. PubMed ID: 34791353
[TBL] [Abstract][Full Text] [Related]
30. Recurrent Isolated Neonatal Hemolytic Anemia: Think About Glutathione Synthetase Deficiency.
Signolet I; Chenouard R; Oca F; Barth M; Reynier P; Denis MC; Simard G
Pediatrics; 2016 Sep; 138(3):. PubMed ID: 27581854
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic trials in the murine model of hereditary tyrosinaemia type I: a progress report.
Grompe M; Overturf K; al-Dhalimy M; Finegold M
J Inherit Metab Dis; 1998 Aug; 21(5):518-31. PubMed ID: 9728332
[TBL] [Abstract][Full Text] [Related]
32. Ex vivo hepatic gene therapy of a mouse model of Hereditary Tyrosinemia Type I.
Overturf K; Al-Dhalimy M; Manning K; Ou CN; Finegold M; Grompe M
Hum Gene Ther; 1998 Feb; 9(3):295-304. PubMed ID: 9508047
[TBL] [Abstract][Full Text] [Related]
33. Identification of a stop mutation in five Finnish patients suffering from hereditary tyrosinemia type I.
St-Louis M; Leclerc B; Laine J; Salo MK; Holmberg C; Tanguay RM
Hum Mol Genet; 1994 Jan; 3(1):69-72. PubMed ID: 8162054
[TBL] [Abstract][Full Text] [Related]
34. [Sepsis, as the presenting form of hereditary tyrosinemia type I].
Iglesias Niubo J; Riudor Taravilla E; Goma Brufau AR; Civit Colas MA; Suñé Gracia JM; Bertrán Sanges JM; Gallart Catalá A
An Esp Pediatr; 1988 Sep; 29(3):235-8. PubMed ID: 3057981
[TBL] [Abstract][Full Text] [Related]
35. Deficient fumarylacetoacetate fumarylhydrolase activity in lymphocytes and fibroblasts from patients with hereditary tyrosinemia.
Kvittingen EA; Halvorsen S; Jellum E
Pediatr Res; 1983 Jul; 17(7):541-4. PubMed ID: 6622096
[TBL] [Abstract][Full Text] [Related]
36. [Biochemical and molecular bases of glutathione synthetase deficiency].
Kanno H
Ryoikibetsu Shokogun Shirizu; 1998; (18 Pt 1):368-70. PubMed ID: 9590072
[No Abstract] [Full Text] [Related]
37. Screening for tyrosinaemia type I.
Hutchesson AC; Hall SK; Preece MA; Green A
Arch Dis Child Fetal Neonatal Ed; 1996 May; 74(3):F191-4. PubMed ID: 8777683
[TBL] [Abstract][Full Text] [Related]
38. Tyrosinaemia type I with normal levels of plasma tyrosine.
de Almeida IT; Leandro PP; Silva MF; Silveira C; da Silva A; de Sousa JS; Duran M
J Inherit Metab Dis; 1990; 13(3):305-7. PubMed ID: 2122090
[No Abstract] [Full Text] [Related]
39. Human hereditary glutathione synthetase deficiency: kinetic properties of mutant enzymes.
Njålsson R; Carlsson K; Bhansali V; Luo JL; Nilsson L; Ladenstein R; Anderson M; Larsson A; Norgren S
Biochem J; 2004 Jul; 381(Pt 2):489-94. PubMed ID: 15056072
[TBL] [Abstract][Full Text] [Related]
40. Missense mutations in the human glutathione synthetase gene result in severe metabolic acidosis, 5-oxoprolinuria, hemolytic anemia and neurological dysfunction.
Dahl N; Pigg M; Ristoff E; Gali R; Carlsson B; Mannervik B; Larsson A; Board P
Hum Mol Genet; 1997 Jul; 6(7):1147-52. PubMed ID: 9215686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
